Abnormal coronary flow in infarct arteries 1 year after myocardial infarction is predicted at 4 weeks by corrected Thrombolysis in Myocardial Infarction (TIMI) frame count and stenosis severity.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  American Journal of Cardiology

• Publication date

  1998-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0002-9149(97)01004-7PMID 9527071
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Simplicity's virtue scorned. Precision comes to TIMI flow grading and the results are ...surprising.

  1996cited by this paper
• TIMI frame count: a quantitative method of assessing coronary artery flow.

  1996cited by this paper
• Angiographic stenosis progression and coronary events in patients with 'stabilized' unstable angina.

  1995cited by this paper
• Frequent reocclusion of patent infarct-related arteries between 4 weeks and 1 year: effects of antiplatelet therapy.

  1995cited by this paper
• Rapid angiographic progression of coronary artery disease in patients with angina pectoris. The role of complex stenosis morphology.

  1995cited by this paper
• Angiographic predictors of reocclusion after thrombolysis: results from the Thrombolysis in Myocardial Infarction (TIMI) 4 trial.

  1995cited by this paper
• Early angiography cannot predict postthrombolytic coronary reocclusion: observations from the GUSTO angiographic study. Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries.

  1994cited by this paper
• Left ventricular function at 3 months after successful thrombolysis. Impact of reocclusion without reinfarction on ejection fraction, regional function, and remodeling.

  1994cited by this paper
• Long-term prognostic importance of patency of the infarct-related coronary artery after thrombolytic therapy for acute myocardial infarction.

  1994cited by this paper
• Culprit lesion morphology and stenosis severity in the prediction of reocclusion after coronary thrombolysis: angiographic results of the APRICOT study. Antithrombotics in the Prevention of Reocclusion in Coronary Thrombolysis.

  1993cited by this paper
• Aspirin Versus Coumadin in the Prevention of Reocclusion and Recurrent Ischemia After Successful Thrombolysis: A Prospective Placebo‐Controlled Angiographic Study Results of the APRICOT Study

  1993cited by this paper
• The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction.

  1993cited by this paper
• Intracoronary artery thrombus formation in unstable angina: a clinical, biochemical and angiographic correlation.

  1993cited by this paper
• The myocardial vasculature during ischemia and reperfusion: a target for injury and protection.

  1993cited by this paper
• Lack of Myocardial Perfusion Immediately After Successful Thrombolysis: A Predictor of Poor Recovery of Left Ventricular Function in Anterior Myocardial Infarction

  1992cited by this paper
• Consequences of reocclusion after successful reperfusion therapy in acute myocardial infarction.

  1991cited by this paper
• Irregular coronary lesion morphology after thrombolysis predicts early clinical instability.

  1991cited by this paper
• Consequences of reocclusion after successful reperfusion therapy in acute myocardial infarction. TAMI Study Group.

  1990cited by this paper
• Thrombolysis in myocardial Infarction (TIMI) trial–phase I

  1990cited by this paper
• Prediction of early recurrent myocardial ischemia and coronary reocclusion after successful thrombolysis: a qualitative and quantitative angiographic study.

  1989cited by this paper
• Effect of intravenous streptokinase as compared with that of tissue plasminogen activator on left ventricular function after first myocardial infarction.

  1989cited by this paper
• Infarct vessel status after intravenous tissue plasminogen activator and acute coronary angioplasty: prediction of clinical outcome.

  1988cited by this paper
• Thrombolysis inMyocardial Infarction (TIMI) Trial, Phase I:acomparison between intravenous tissue plasminogen activator andintravenous streptokinase*

  1987cited by this paper
• Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.

  1987cited by this paper
• Effect of intravenous streptokinase on left ventricular function and early survival after acute myocardial infarction.

  1987cited by this paper
• Usefulness of recanalization to luminal diameter of 0.6 millimeter or more with intracoronary streptokinase during acute myocardial infarction in predicting "normal" perfusion status, continued arterial patency and survival at one year.

  1987cited by this paper
• Factors influencing reocclusion after coronary thrombolysis for acute myocardial infarction.

  1986cited by this paper
• Coronary angiographic morphology in myocardial infarction: a link between the pathogenesis of unstable angina and myocardial infarction.

  1985cited by this paper
• Validation in dogs of a rapid digital angiographic technique to measure relative coronary blood flow during routine cardiac catheterization.

  1985cited by this paper
• Application of digital techniques to selective coronary arteriography: use of myocardial contrast appearance time to measure coronary flow reserve.

  1984cited by this paper
• Rethrombosis after reperfusion with streptokinase: importance of geometry of residual lesions.

  1984cited by this paper
• Is transluminal coronary angioplasty mandatory after successful thrombolysis? Quantitative coronary angiographic study.

  1983cited by this paper
• The Stunned Myocardium: Prolonged, Postischemic Ventricular Dysfunction

  1982cited by this paper

• Quantitatively Assessed Emphysema Severity on HRCT Independently Predicts Coronary Artery Disease in COPD: A Retrospective Cohort Study

  2025cites this paper
• Diagnostic comparison of automatic and manual TIMI frame-counting-generated quantitative flow ratio (QFR) values

  2022cites this paper
• Pathophysiology and diagnosis of coronary microvascular dysfunction in ST-elevation myocardial infarction

  2019cites this paper
• Fluoroscopy Assisted Scoring of Myocardial Hypoperfusion (FLASH) ratio as a novel predictor of mortality after primary PCI in STEMI patients.

  2016cites this paper
• Re-infarction after primary percutaneous coronary intervention

  2015cites this paper
• Clinical importance of hyperemic coronary blood flow (thrombolysis in myocardial infarction-intravenous flow) after primary percutaneous coronary intervention

  2014cites this paper
• No-reflow: incidence and detection in the cath-lab.

  2013cites this paper
• myocardial infarction with subsequent mortality Association of creatinine and creatinine clearance on presentation in acute

  2011cites this paper
• The prognostic value of combined fractional flow reserve and TIMI frame count measurements in patients with stable angina pectoris and acute coronary syndrome.

  2010cites this paper
• Reperfusion therapy, reocclusion and disease progression in acute myocardial infarction

  2010cites this paper
• The smoker’s paradox after successful fibrinolysis: reduced risk of reocclusion but no improved long-term cardiac outcome

  2009cites this paper
• A method towards automated thrombolysis in myocardial infarction (TIMI) frame counting using 3D reconstruction

  2009cites this paper
• Letter to the Editor Coronary flow, VO 2 peak and anaerobic threshold in patients with dilated cardiomyopathy

  2007cites this paper
• Coronary flow, VO2 peak and anaerobic threshold in patients with dilated cardiomyopathy.

  2007cites this paper
• Antiplatelet therapy and progression of coronary artery disease: a placebo-controlled trial with angiographic and clinical follow-up after myocardial infarction.

  2007cites this paper
• Early management of ST-segment elevation myocardial infarction.

  2006cites this paper
• Association of a History of Systemic Hypertension With Mortality, Thrombotic, and Bleeding Complications Following Non‐ST‐Segment Elevation Acute Coronary Syndrome

  2006cites this paper
• Risk Stratification and Risk Modification in Patients with Acute Coronary Syndromes

  2006cites this paper
• Association of glomerular filtration rate on presentation with subsequent mortality in non-ST-segment elevation acute coronary syndrome; observations in 13,307 patients in five TIMI trials

  2005cites this paper
• References on a Wide Variety of Topics Pertaining to Coronary Artery Blood Flow and Patency

  2004cites this paper
• Association of Epicardial and Tissue-Level Reperfusion with Left Ventricular End-Diastolic Pressures in ST-Elevation Myocardial Infarction

  2004cites this paper
• High-grade infarct-related stenosis after successful thrombolysis: strong predictor of reocclusion, but not of clinical reinfarction.

  2004cites this paper
• Association of peripheral neutrophilia with adverse angiographic outcomes in ST-elevation myocardial infarction.

  2004cites this paper
• Effect of rescue or adjunctive percutaneous coronary intervention of the culprit artery after fibrinolytic administration on epicardial flow in nonculprit arteries.

  2004cites this paper
• Association of glomerular filtration rate on presentation with subsequent mortality in non-ST-segment elevation acute coronary syndrome; observations in 13,307 patients in five TIMI trials.

  2004cites this paper
• Sequential risk stratification using TIMI risk score and TIMI flow grade among patients treated with fibrinolytic therapy for ST-segment elevation acute myocardial infarction.

  2004cites this paper
• Coronary and myocardial angiography: angiographic assessment of both epicardial and myocardial perfusion.

  2004cites this paper
• Relation between the TIMI frame count and the degree of microvascular injury after primary coronary angioplasty in patients with acute anterior myocardial infarction

  2004cites this paper
• Association of creatinine and creatinine clearance on presentation in acute myocardial infarction with subsequent mortality.

  2003cites this paper
• Myocardial reperfusion: its assessment and its relation to clinical outcomes.

  2003cites this paper
• Impact of contrast agent type (ionic versus nonionic) used for coronary angiography on angiographic, electrocardiographic, and clinical outcomes following thrombolytic administration in acute myocardial infarction

  2001cites this paper
• Comparative Efficacy of Primary Angioplasty with Stent Implantation and Thrombolysis in Restoring Basal Coronary Artery Flow in Acute ST Segment Elevation Myocardial Infarction: Quantitative Assessment Using the Corrected TIMI Frame Count

  2001cites this paper
• Keeping the coronary arteries open: current opportunities.

  2001cites this paper
• Assessing coronary blood flow dynamics with the TIMI frame count method: Comparison with simultaneous intracoronary Doppler and ultrasound

  2001cites this paper
• Importance of the TIMI frame count: implications for future trials

  2000cites this paper
• Relationship between corrected TIMI frame counts at three weeks and late survival after myocardial infarction.

  2000cites this paper
• Occluded infarct-related arteries and clinical events.

  2000cites this paper
• Impact of injections during diagnostic coronary arteriography on coronary patency in the setting of acute myocardial infarction from the TIMI trials. Thrombolysis In Myocardial Infarction.

  2000cites this paper
• Improved coronary artery flow after coronary angioplasty in patients with unstable angina.

  2000cites this paper
• Assessment of change of coronary artery flow using corrected TIMI frame count following abciximab adminstration during primary angioplasty for acute myocardial infarction

  2000cites this paper
• Association Between White Blood Cell Count, Epicardial Blood Flow, Myocardial Perfusion, and Clinical Outcomes in the Setting of Acute Myocardial Infarction: A Thrombolysis In Myocardial Infarction 10 Substudy

  2000cites this paper
• Medical treatment for acute coronary syndromes.

  2000cites this paper
• Estimation of Coronary Flow Reserve Using the Thrombolysis In Myocardial Infarction (TIMI) Frame Count Method

  1999cites this paper
• Effect of potential confounding factors on the thrombolysis in myocardial infarction (TIMI) trial frame count and its reproducibility.

  1999cites this paper
• Coronary artery flow ten weeks after myocardial infarction or unstable angina: effects of combined warfarin and aspirin therapy.

  1999cites this paper
• Angiographic frame counts 90 minutes after streptokinase predict left ventricular function at 48 hours following myocardial infarction

  1999cites this paper
• The sundial and the stopwatch.

  1999cites this paper
• Determinants of coronary blood flow after thrombolytic administration. TIMI Study Group. Thrombolysis in Myocardial Infarction.

  1999cites this paper
• Impaired coronary blood flow in nonculprit arteries in the setting of acute myocardial infarction. The TIMI Study Group. Thrombolysis in myocardial infarction.

  1999cites this paper
• Estimation of coronary flow reserve using the Thrombolysis In Myocardial Infarction (TIMI) frame count method.

  1999cites this paper
• Weight-adjusted dosing of TNK-tissue plasminogen activator and its relation to angiographic outcomes in the thrombolysis in myocardial infarction 10B trial. TIMI 10B Investigators.

  1999cites this paper
• The corrected TIMI frame count. The new gold standard?

  1998cites this paper